openPR Logo
Press release

New Report Examines the Liposome Drug Delivery Market

11-05-2017 10:55 AM CET | Health & Medicine

Press release from: Transparency Market Research

Liposomes are small spherical-shaped artificial vesicles synthesized from phospholipids and cholesterol. They are colloidal carriers and range from 0.01 to 5.0 μm in diameter. These are lipid bilayer vesicles having hydrophilic and hydrophobic properties. Due to these properties liposomes have an advantage of encapsulating hydrophobic as well as hydrophilic drugs and delivering them to the targeted site in the body. Thus, liposomes are promising systems for targeted drug delivery. Liposomes are successfully used for encapsulating various drug molecules such as acyclovir, tropicamaide, chloroquine diphosphate, paclitaxel, and cyclosporine. Many therapeutic agents such as antimicrobials, anticancer drugs, genetic materials, vaccines, macromolecules, and proteins can be encapsulated in liposomes. Liposomes are employed as drug carriers for targeted drug therapy for various diseases, as they are biocompatible and biodegradable.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=28571

The classification of liposomes is based on its structural properties or on the method of preparation used. Structurally, liposomes are classified into the following groups: multilamellar large vesicles (MLV), oligolamellar vesicles (OLV), unilamellar vesicles (UV), small unilamellar vesicles (SUV), medium-sized unilamellar vesicles (MUV), large unilamellar vesicles (LUV), giant unilamellar vesicles (GUV), and multivesicular vesicles (MVV). In terms of preparation method used, liposomes can be classified into the following types: reverse phase evaporation method for single or oligolamellar vescile (REV), multilamellar vesicles (MLV) made by reverse phase evaporation method, stable plurilamellar vesicles, (FATMLV) frozen and thawed, vesicles prepared by extrusion method (VET), vesicles prepared by fusion (FUV), vesicles prepared by french press (FPV), dehydration?rehydration vesicles (DRV), and bubblesomes (BSV).

Development in scientific research in recent years has led to the rapid expansion of the global liposome drug delivery market. Increased understanding of targeted drug delivery system has fuelled the liposome drug delivery system market. Advantages such as improvement and control over pharmacokinetics and pharmacodynamics, decreased toxicity, and enhanced activity of drugs against intracellular pathogens are key divers for pharmaceutical companies to invest in the global liposomes drug delivery market. Currently, there are a number of liposomal products such as ambisome, myocet, doxil, depoCyt, etc., approved by the FDA for commercial usage. However, low solubility, short half-life and high production cost are key restraints of the global liposome drug delivery market.

In terms of type of industry, the liposome drug delivery market can be segmented into pharmaceutical, cosmetic, food, and farming. The pharmaceutical industry segment led the global liposomes market due to rapid advancements in targeted drug delivery systems. In terms of product, the market can be segmented into liposomal doxorubicin, liposomal amphoteracin B, and liposomal paclitaxel. Liposomal amphoteracin B is used in the treatment of various fungal and parasitic infections. In terms of application, the global liposomes drug delivery market can be segmented into therapeutic and clinical. Therapeutic applications include occular and pulmonary applications, whereas clinical applications consists of cancer (antitumor) therapy and fungal and microbial infection therapy. Ongoing research and advancement in liposome design are leading to new applications for the delivery of new biotechnology products such as recombinant proteins antisense oligonucleotides and cloned genes.

Make an Enquiry @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=28571

In terms of geography, the global liposomes drug delivery market can be segmented into North America (Canada, the U.S., and Mexico), Europe (Germany, France, the U.K., Russia, and Italy), Asia Pacific (Japan, China, Korea, India, and Southeast Asia), Latin America, and Middle East & Africa. North America is a leading market for liposomes drug delivery systems due to increase in novel technologies in targeted drug delivery systems. The market is anticipated to expand during the forecast period in other parts of the globe as well.

Prominent manufacturers operating in the global liposome drug delivery market include Johnson & Johnson, Sun Pharmaceutical, Teva Pharmaceutical Industries Ltd., Novartis AG, Gilead Sciences, Inc., Kingond Pharm, and Celsion Corporation.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New Report Examines the Liposome Drug Delivery Market here

News-ID: 801700 • Views:

More Releases from Transparency Market Research

Well Intervention Market Valued at USD 7.9 Billion in 2022, Forecast to Grow at 5.7% CAGR Through 2031
Well Intervention Market Valued at USD 7.9 Billion in 2022, Forecast to Grow at …
The global well intervention market is set to experience steady growth as subsea exploration activities increase and energy consumption continues to surge. Valued at US$ 7.9 Bn in 2022, the market is projected to advance at a compound annual growth rate (CAGR) of 5.7% from 2023 to 2031, reaching US$ 13.1 Bn by the end of 2031. Driven by the depletion of conventional oil reserves and rising drilling costs, well
Flexible Power Plants with Medium Speed Generators Market to Hit 11.4 GW by 2034, Growing at 4.1% CAGR
Flexible Power Plants with Medium Speed Generators Market to Hit 11.4 GW by 2034 …
The global flexible power plants market powered by medium speed generators (300-1200 rpm) is set for steady growth, driven by the increasing flexibility requirements in power grids and the decentralization of power generation. In 2023, the market volume was 7.3 GW and is projected to grow at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2034, reaching 11.4 GW by the end of 2034. This growth is
Global Underwater Monitoring Market in Oil & Gas Sector Set to Hit USD 1.8 Billion by 2034
Global Underwater Monitoring Market in Oil & Gas Sector Set to Hit USD 1.8 Billi …
The global underwater monitoring system for oil and gas market is set for significant growth, driven by rising oil & gas consumption and a surge in offshore accidents. Valued at US$ 879.0 Mn in 2023, the market is forecast to grow at a compound annual growth rate (CAGR) of 6.6% from 2024 to 2034, reaching US$ 1.8 Bn by the end of 2034. Advanced subsea acoustic monitoring systems, integrated sensor
Global PVC Cling Films Market Projected to Reach USD 1.1 Billion by 2032, Says Transparency Market Research
Global PVC Cling Films Market Projected to Reach USD 1.1 Billion by 2032, Says T …
The global luxury boxes market is set for steady growth, driven by rising demand for premium personal care and high-end food & beverage products. Valued at US$ 8.3 Bn in 2023, the market is projected to expand at a compound annual growth rate (CAGR) of 4.1% from 2024 to 2032, reaching US$ 12.1 Bn by 2032. Increasing consumer demand for exclusive, aesthetically appealing packaging that enhances brand value and offers

All 5 Releases


More Releases for Liposomes

Digitized overhaul to drive the Liposomes Market
The Liposomes Market is expected to grow on a healthy note further. The current scenario is such that virtual monitoring tools are being called for. They act as a precision factor for the healthcare vertical. With the turning out to be more accessible for patients and providers alike, several post-operative intervention options are being made available for preventing hospital re-admittance and complications. With cost-effectiveness rendered as well, the healthcare vertical
The Liposomes Market to Stick To Digitized Innovation
The Liposomes Market is bound to witness stupendous growth going forward. With advancements in technology, healthcare organizations are into the development of a holistic strategy for building awareness regarding advanced healthcare infrastructure. eBooks and blog posts are also being used to increase the benevolence amongst patients. The healthcare vertical is expected to move in this direction shortly. Liposomes are a novel system widely used in the field of drug delivery, gene
Liposomes Market Registering a Strong Growth by 2025
Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer. Liposomes can be divided into two categories on the basis of their size and the number of bilayers – unilamellar vesicles and multilamellar vesicles. Unilamellar vesicles-aqueous solution is enclosed within vesicles
Liposomes Market Is Progressing Towards A Strong Growth By 2025
Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer. Liposomes can be divided into two categories on the basis of their size and the number of bilayers – unilamellar vesicles and multilamellar vesicles. Unilamellar vesicles-aqueous solution is enclosed within vesicles
Liposomes Market Research Report - Forecast 2017 – 2025
Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer. Liposomes can be divided into two categories on the basis of their size and the number of bilayers – unilamellar vesicles and multilamellar vesicles. Unilamellar vesicles-aqueous solution is enclosed within vesicles
Liposomes Market to be at Forefront by 2025
Liposomes are spherical nano-sized bilayered vesicles or “bags” in which an aqueous volume is entirely closed within a membrane composed of lipid (fat) molecules, usually phospholipids. The components within the bilayer define the rigidity/ fluidity and charge of the bilayer. Liposomes can be divided into two categories on the basis of their size and the number of bilayers – unilamellar vesicles and multilamellar vesicles. Unilamellar vesicles-aqueous solution is enclosed within vesicles